KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Gilead Sciences' Income from Continuing Operations rose 14357.54% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 billion, marking a year-over-year increase of 707699.12%. This contributed to the annual value of $479.0 million for FY2024, which is 9146.47% down from last year.
  • Per Gilead Sciences' latest filing, its Income from Continuing Operations stood at $3.1 billion for Q3 2025, which was up 14357.54% from $2.0 billion recorded in Q2 2025.
  • Gilead Sciences' 5-year Income from Continuing Operations high stood at $3.1 billion for Q3 2025, and its period low was -$4.2 billion during Q1 2024.
  • Its 5-year average for Income from Continuing Operations is $1.2 billion, with a median of $1.5 billion in 2021.
  • In the last 5 years, Gilead Sciences' Income from Continuing Operations soared by 810000.0% in 2023 and then tumbled by 52388.21% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Income from Continuing Operations stood at $376.0 million in 2021, then skyrocketed by 334.31% to $1.6 billion in 2022, then decreased by 13.29% to $1.4 billion in 2023, then rose by 25.85% to $1.8 billion in 2024, then surged by 71.27% to $3.1 billion in 2025.
  • Its Income from Continuing Operations was $3.1 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $1.3 billion in Q1 2025.